Numerous pathogenetic aspects of transgenic AD models can be rescued by ablating the tau gene [45–47]; however, other studies show that aggregated Aβ can enhance tau pathology or conversely that aggregated tau may enhance Aβ toxicity [47–50]. The gene discussed is MAPT; the disease is Alzheimer disease.